Cargando…
ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma
BACKGROUND: Glioma is the most common and aggressive tumor in the adult brain. Recent studies have indicated that Zinc finger DHHC-type palmitoyltransferases (ZDHHCs) play vital roles in regulating the progression of glioma. ZDHHC15, a member of the ZDHHCs family, participates in various physiologic...
Autores principales: | Liu, Zhen-Yuan, Lan, Tian, Tang, Feng, He, Yong-Ze, Liu, Jin-Sheng, Yang, Jin-Zhou, Chen, Xi, Wang, Ze-Fen, Li, Zhi-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169355/ https://www.ncbi.nlm.nih.gov/pubmed/37161425 http://dx.doi.org/10.1186/s12885-023-10883-6 |
Ejemplares similares
-
ARL3 is downregulated and acts as a prognostic biomarker in glioma
por: Wang, Yulin, et al.
Publicado: (2019) -
Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression
por: Tang, Feng, et al.
Publicado: (2022) -
ACT-15 AD-SGE-REIC GENE THERAPY FOR MALIGNANT GLIOMA
por: Kurozumi, Kazuhiko, et al.
Publicado: (2019) -
SYDE1 Acts as an Oncogene in Glioma and has Diagnostic and Prognostic Values
por: Han, Zhenyuan, et al.
Publicado: (2021) -
CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells
por: Wu, Hailong, et al.
Publicado: (2021)